These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8269456)

  • 1. Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia.
    Kurihara T; Akimoto M; Abe K; Ishiguro H; Niimi A; Maeda A; Shigemoto M; Yamashita K; Yokoyama I; Suzuki Y
    Clin Ther; 1993; 15(5):890-8. PubMed ID: 8269456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis.
    Floreani A; Variola A; Niro G; Premoli A; Baldo V; Gambino R; Musso G; Cassader M; Bo S; Ferrara F; Caroli D; Rizzotto ER; Durazzo M
    Am J Gastroenterol; 2008 Aug; 103(8):1959-65. PubMed ID: 18564121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin].
    Spagnolli W; Ramponi C; Focher C; Dal Piaz A; Torboli P; Miori R; De Venuto G
    Recenti Prog Med; 1996 Nov; 87(11):538-42. PubMed ID: 9122535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pravastatin in treatment of hypercholesterolemia in non-insulin-dependent diabetes patients.
    Soonthornpun S; Rattarasarn C; Leelawattana R; Thamprasit A
    J Med Assoc Thai; 1997 Jan; 80(1):9-15. PubMed ID: 9078811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term experience with pravastatin in clinical research trials.
    McGovern ME; Mellies MJ
    Clin Ther; 1993; 15(1):57-64. PubMed ID: 8458055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis.
    Batta AK; Salen G; Mirchandani R; Tint GS; Shefer S; Batta M; Abroon J; O'Brien CB; Senior JR
    Am J Gastroenterol; 1993 May; 88(5):691-700. PubMed ID: 8480734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [-Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy-].
    Rudi J; Schönig T; Stremmel W
    Z Gastroenterol; 1996 Mar; 34(3):188-91. PubMed ID: 8650973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.
    Mallon PW; Miller J; Kovacic JC; Kent-Hughes J; Norris R; Samaras K; Feneley MP; Cooper DA; Carr A
    AIDS; 2006 Apr; 20(7):1003-10. PubMed ID: 16603852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P; Echevaría-Vázquez D; Petrov V
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of primary biliary cirrhosis with p-tolylmethylcarbinol nicotinic acid ester in combination with alpha-naphthylacetic acid.
    Kaserbacher R; Propst A; Vogel W
    Wien Klin Wochenschr; 1996 Nov; 108(22):722-6. PubMed ID: 8986034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic effects of ursodeoxycholic acid in primary biliary cirrhosis.
    Leevy CB; Holt J; Buniak B
    J Assoc Acad Minor Phys; 1993; 4(1):30-2. PubMed ID: 8425102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
    Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
    Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.
    Heathcote EJ
    Hepatology; 2000 Apr; 31(4):1005-13. PubMed ID: 10733559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
    Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
    Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
    Twaddell WS; Lefkowitch J; Berk PD
    Semin Liver Dis; 2008 Feb; 28(1):128-34. PubMed ID: 18293283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
    Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
    Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.